Clinical Trials Browser

Phase 1/2 × Infusions, Intravenous × Other solid neoplasm × Clear all

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors